(Q28316492)
Statements
An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China (English)
0 references
June 1992
0 references
21
0 references
3
0 references
564-73
0 references